Seroprevalence of Hepatitis E among Iranian Renal Transplant Recipients

How to Cite:Rostamzadeh Khameneh Z, Sepehrvand N, Masudi S. Seroprevalence of Hepatitis E among Iranian Renal Transplant Recipients.Hepat Mon.2011;11(8):646-651.https://doi.org/10.5812/kowsar.1735143X.690.

Abstract

Background: Renal transplant recipients are known to be susceptible to viral infections, with more severe clinical presentations compared to healthy persons. Hepatitis E is generally a self-limited disease, which is caused by hepatitis E virus. Recently, hepatitis E has become more important in organ transplant recipients, because of new findings regarding the potential for chronic infections in this patient group.
Objectives: This study aimed to evaluate the seroprevalence of anti-HEV IgG among kidney transplant recipients in Urmia, in the north-western region of Iran.
Patients and Methods: 91 patients were selected randomly from amongst patients who had undergone kidney transplantation in Urmia, Iran. Each patient was tested for the presence of anti-HEV IgG antibody using an enzyme-linked immunosorbent assay (ELISA, Dia.Pro; Diagnostic Bioprobes, Italy).
Results: 28 subjects (30.8%) were seropositive for anti-HEV IgG. Seropositive patients were generally older than seronegative patients (P = 0.009). There was no correlation between HEV infection and the level of education (P = 0.206), the history of blood transfusion (P = 0.164), or history of pre-transplantation hemodialysis (P = 0.228). There was no significant difference in the serum alanine aminotransferase (ALT) levels of the anti-HEV seropositive and seronegative patients. Multinomial logistic regression analysis indicated no significant relationship between HEV infection and increase in ALT levels, even after controlling for treatment with azathioprine (P = 0.79, OR = 1.12; 95% CI: 0.45-2.76).
Conclusion: The anti-HEV IgG antibody has a high prevalence in Iranian kidney transplant recipients, and it is significantly higher in comparison with previous studies in the general population or in hemodialysis patients.

Implication for health policy/practice/research/medical education:
The prevalence rate of anti-HEV IgG in transplant recipients is independent of its prevalence in the general population. In the setting of transplant recipients, the clinicians should not look merely for clinical evidence to consider hepatitis E.
Please cite this paper as:
Khameneh ZR, Sepehrvand N, Masudi S. Seroprevalence of Hepatitis E among Iranian Renal Transplant Recipients. Hepat Mon. 2011;11(8):646-51. [DOI: 10.5812/kowsar.1735143X.690]

Keywords

Hepatitis E

ELISA

Anti-HEV IgG

Renal transplantation

Full Text

Full text is available in PDF

Import into EndNote Import into BibTex

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 23
Last Update: 3 days ago
Scopus by Title: 23
Last Update: 3 days ago
Scopus by Title (Ref): 0
Last Update: 3 days ago
CrossRef: 2
Last Update: 6 days ago

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Zakieh Rostamzadeh Khameneh:[PubMed][Scholar]
Nariman Sepehrvand:[PubMed][Scholar]
Sima Masudi:[PubMed][Scholar]

Official Journal of Research Center for Gastroenterology and Liver Diseases

Outlines

Seroprevalence of Hepatitis E among Iranian Renal Transplant Recipients

Abstract

Full Text

Crossmark

Checking

Last Update: 3 days ago

Last Update: 3 days ago

Last Update: 3 days ago

Last Update: 6 days ago